8145--Medication Return Envelopes (VA-24-00012799)
ID: 36C77024Q0051Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

PSC

SPECIALIZED SHIPPING AND STORAGE CONTAINERS (8145)
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for the procurement of Medication Return Envelopes under solicitation number 36C77024Q0051. This initiative aims to supply multiple Veterans Affairs Medical Centers (VAMCs) and Consolidated Mail Outpatient Pharmacies (CMOP) with a system for the safe disposal of scheduled and non-controlled medications over a five-year period, from November 2024 to October 2029. The program is critical for enhancing medication safety, preventing accidental overdoses, and reducing environmental waste, with an estimated budget of $47 million. Interested vendors must submit their bids by October 14, 2024, at 5 PM Central Time, and are encouraged to monitor SAM.gov for further solicitation details, which will be posted on September 13, 2024. For inquiries, contact Contract Specialist Diana Olson at Diana.Olson@va.gov or 913-684-0153.

    Point(s) of Contact
    Files
    Title
    Posted
    The document outlines a Request for Proposal (RFP) from the Department of Veterans Affairs for a contract related to the disposal of unwanted medications through a medication return envelope system. The acquisition seeks a contractor to manage bulk storage, delivery, processing, destruction, and reporting of medication return envelopes for Veterans over a five-year period, with an estimated budget of $47 million. The contractor must have a service agreement with USPS, comply with DEA regulations, and ensure the privacy and security of Veterans' information throughout the process. The program aims to enhance medication safety, prevent accidental overdoses, and reduce environmental waste. Key requirements include tamper-evident packaging, postage-paid shipping, tracking systems, and quarterly reporting of envelope destruction metrics. The solicitation encourages participation from small businesses, especially veteran-owned firms. The successful bidder must deliver products to various VA facilities while adhering to safety regulations and performance requirements, contributing to the VA's mission of sustainable healthcare practices for Veterans.
    The Department of Veterans Affairs is issuing a presolicitation notice for the procurement of Medication Return Envelopes under solicitation number 36C77024Q0051. The requirement aims to supply multiple Veterans Affairs Medical Centers (VAMCs) and Consolidated Mail Outpatient Pharmacies (CMOP) over five ordering periods spanning from November 2024 to October 2029. The key items include a case of 250 medication recovery envelopes designed for the safe disposal of scheduled and non-controlled medications, with specific provisions for tracking and non-descript packaging. Bids are due by October 14, 2024, at 5 PM Central Time, with final solicitation details to be posted on SAM.gov on September 13, 2024. The submission process invites open market sources to email quotes and specified samples. The solicitation is unrestricted, encouraging broad participation, and emphasizes the importance of adhering to deadlines and monitoring for any updates on the SAM.gov platform. The notice reflects the VA's commitment to securing reliable disposal solutions for medications, ensuring compliance with safety regulations for veterans' healthcare facilities.
    Similar Opportunities
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Cyclobenzaprine HCL Tablets under solicitation number 36E79725R0009. This unrestricted procurement aims to secure a reliable supply of these essential pharmaceuticals for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), reflecting the government's commitment to providing necessary medications to veterans and associated healthcare systems. The contract will have an initial duration of one year, with the possibility of four additional one-year extensions, and interested vendors must provide specific drug labeling along with a unique National Drug Code (NDC). The RFP is expected to be released electronically around December 20, 2024, with a submission deadline set for January 3, 2025. For further inquiries, interested parties can contact Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Carbidopa/Levodopa SA Tablet
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) 36E79725R0008 for the procurement of Carbidopa/Levodopa sustained release (SA) tablets, aimed at ensuring a continuous supply of these medications for various federal health services, including the Department of Defense and the Bureau of Prisons. The contract will be awarded for an initial period of one year, with the option to extend for four additional one-year periods, requiring offerors to provide unique branding and packaging without overlapping labels. The estimated annual usage totals approximately 119,875 bottles across two dosage forms, highlighting the importance of these medications in treating Parkinson's disease and related conditions. Interested parties should note that the electronic solicitation is expected to be issued around January 3, 2026, with offers due by January 17, 2026; questions can be directed to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Warfarin NA tablets under solicitation number VA-25-00012328. The objective of this procurement is to establish a reliable supply contract for Warfarin tablets to ensure consistent availability and pricing through the VA and Department of Defense's Pharmaceutical Prime Vendor Programs. This initiative is crucial for maintaining a steady supply of essential pharmaceuticals, thereby supporting the government’s commitment to high-quality patient care and regulatory compliance. Interested offerors must submit their proposals by December 31, 2024, at 2:30 PM CST, and should direct any inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--Metformin IR Tablets - REPACK PROGRAM
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Metformin HCL IR Tablets under solicitation number 36E79725R0013. This procurement aims to ensure a consistent supply of Metformin for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center, with a contract term of one year and four optional annual extensions. The successful bidders must provide unique drug labeling with a distinct National Drug Code (NDC), as the packaging must exclusively display the contractor's label without overlapping with others. The solicitation is expected to be released electronically on January 21, 2025, with a submission deadline of February 4, 2025. Interested parties can direct inquiries to Contracting Officer Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852.
    G099--678 Methadone Dosing
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for Methadone Dosing services at the Southern Arizona VA Healthcare System (SAVAHCS). The procurement aims to provide comprehensive substance use disorder treatment, including daily methadone dosing for up to 75 veterans, urine toxicology screenings, and community-based opiate substitution treatment services, all while adhering to strict quality assurance standards. This initiative underscores the VA's commitment to ensuring accessible and effective healthcare services for veterans dealing with substance use issues. Proposals are due by January 13, 2025, at 12:00 PM Pacific Time, and interested parties can contact Danielle Trudeau at danielle.trudeau@va.gov or by phone at 562-766-2263 for further information.
    6505--Baclofen Tablets (VA-25-00026620)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0015 for the procurement of Baclofen Tablets, aimed at ensuring a reliable supply for various federal health facilities, including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The procurement will cover a one-year contract with four additional pre-priced option years, requiring offerors to provide products labeled with their unique National Drug Code (NDC) numbers. This initiative is critical for maintaining uninterrupted access to essential medications for veterans and other federal health service users. Interested suppliers should note that the solicitation will be electronically posted on or around December 30, 2024, with a submission deadline of January 13, 2025; inquiries can be directed to Contract Specialist Adrienne A. Albachiara at adrienne.albachiara@va.gov.
    R614--PHARMACY/WALLTOWALLINVENTORY l CO (VA-25-00027823) 589-25-1-5622-0115
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to provide Annual Pharmacy Wall to Wall Inventory services for the Harry S Truman VA Medical Center. The contract, identified as 36C25525Q0099, requires the contractor to conduct a comprehensive physical inventory of medications and supplies across multiple pharmacy locations, ensuring accurate auditing and financial reporting within a 24-hour timeframe. This procurement is crucial for maintaining the integrity of pharmaceutical practices and ensuring quality care for veterans, with an estimated total award amount of $16.5 million over the contract period from February 17, 2025, to February 28, 2029. Interested parties should contact Contracting Specialist Mark S Socha at mark.socha@va.gov for further details and to discuss eligibility, including set-aside opportunities for small businesses and service-disabled veteran-owned businesses.
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting offers for the procurement of Verapamil Hydrochloride (HCL) Tablets, aimed at establishing a contract for the supply of this pharmaceutical product through the VA and Department of Defense Pharmaceutical Prime Vendor Programs. The solicitation requires compliance with current Good Manufacturing Practices (cGMP) and mandates a unique National Drug Code (NDC) for each product offered, ensuring adherence to FDA regulations and drug supply chain security measures. Interested contractors must submit their proposals by December 31, 2024, at 2:30 PM CST, and can direct inquiries to Contract Specialist Nicholas I. McGregor at Nicholas.McGregor@va.gov for further information.
    Q517--Staffing Service for Murfreesboro CMOP
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for staffing services at the Murfreesboro Consolidated Mail Outpatient Pharmacy (CMOP) in Tennessee, specifically targeting Service-Disabled Veteran-Owned Small Businesses (SDVOSBs). The contract requires the provision of pharmacists, pharmacy technicians, and shipper/packer personnel to support operations that process over 15 million prescriptions annually, ensuring compliance with VA guidelines and operational standards. This initiative is crucial for maintaining efficient pharmaceutical services for veterans, reflecting the government's commitment to quality healthcare delivery. Interested contractors must submit their proposals by the revised deadline of July 30, 2024, with a minimum guaranteed contract value of $5 million and a maximum of $300 million over the contract's duration, which spans from April 1, 2023, to March 31, 2028. For further inquiries, potential bidders can contact Nicholas L. Schulte at nicholas.schulte1@va.gov or Christy Pendlay at Christy.Pendlay@va.gov.